Authors:
Hryszko, T
Malyszko, J
Malyszko, JS
Brzosko, S
Pawlak, K
Mysliwiec, M
Citation: T. Hryszko et al., A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients, NEPH DIAL T, 16(8), 2001, pp. 1692-1696
Authors:
Brzosko, S
Lebkowska, U
Malyszko, J
Hryszko, T
Pawlak, K
Mysliwiec, M
Citation: S. Brzosko et al., Correlation between carotid intima-media thickness and hematocrit and hemoglobin values in renal transplant recipients, CLIN TRANSP, 15(5), 2001, pp. 349-353
Authors:
Malyszko, J
Malyszko, JS
Hryszko, T
Mysliwiec, M
Citation: J. Malyszko et al., Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients, AM J NEPHR, 21(5), 2001, pp. 373-377
Authors:
Braszko, JJ
Kaminski, KA
Hryszko, T
Jedynak, W
Brzosko, S
Citation: Jj. Braszko et al., Diverse effects of prolonged physical training on learning of the delayed non-matching to sample by rats, NEUROSCI RE, 39(1), 2001, pp. 79-84
Authors:
Hryszko, T
Malyszko, J
Malyszko, JS
Brzosko, S
Mysliwiec, M
Citation: T. Hryszko et al., Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor, THROMB RES, 104(4), 2001, pp. 233-238
Authors:
Malyszko, J
Zbroch, E
Wolczynski, S
Malyszko, JS
Hryszko, T
Mysliwiec, M
Citation: J. Malyszko et al., Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy, AM J NEPHR, 20(3), 2000, pp. 180-186